High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$757K
$757,453
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
MAZE
S
Maze Therapeutics, Inc.
Bachrodt Amy
• Officer • SVP, Finance
10b5-1 SellΔOwn -14.2%
2026-04-01
$64,510
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 SellΔOwn -14.2%
|
2026-04-01 | $64,510 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
Other
|
2026-04-01 | $26,050 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 Sell
|
2026-04-01 | $9,101 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
Other
|
2026-03-02 | $52,100 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 Sell
|
2026-03-02 | $57,774 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bachrodt Amy
• Officer • SVP, Finance
10b5-1 SellΔOwn -22.2%
2026-03-02
$168,237
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 SellΔOwn -22.2%
|
2026-03-02 | $168,237 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 Sell
|
2026-02-02 | $34,321 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
Other
|
2026-02-02 | $50,474 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
Other
|
2026-02-02 | $1,626 | M | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 Sell
|
2026-02-02 | $8,830 | S | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bachrodt Amy
• Officer • SVP, Finance
10b5-1 SellΔOwn -22.9%
2026-02-02
$187,068
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 SellΔOwn -22.9%
|
2026-02-02 | $187,068 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
Other
|
2026-01-22 | $26,019 | M | Form 4 |
|
MAZE
S
Maze Therapeutics, Inc.
Bachrodt Amy
• Officer • SVP, Finance
10b5-1 SellΔOwn -27.8%
2026-01-22
$227,612
|
||||||
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
10b5-1 SellΔOwn -27.8%
|
2026-01-22 | $227,612 | S | Form 4 |
| MAZE |
Maze Therapeutics, Inc.
|
Officer • SVP, Finance
Other
|
2026-01-22 | $26,081 | M | Form 4 |